Wound Management News

Cipher Pharmaceuticals announced in a press release that Health Canada has accepted to review its new drug submission for Sitavig for treating recurrent herpes labialis in adults.

The double-edged razor blade was the sharpest blade used in dermatologic surgery, according to recently published study results.

Miltefosine was well-tolerated and effectively treated complicated Old World cutaneous and mucosal leishmaniasis, making it an ideal first-line treatment option, according to findings published in Open Forum Infectious Diseases.

Findings that fractional microneedling plus topical anesthesia decreased pain sensation better than topical anesthesia alone when used prior to microneedling procedures for treating postacne scarring was among recent developments in cosmetic dermatology reported on Healio.com.

A 532-nm potassium titanyl phosphate laser was as safe and effective as a 595-nm pulsed dye laser in treating erythematous surgical scars, according to recently published study results.

Surgical Specialties Corp. announced in a press release it has acquired all shares of Jestetten, Germany-based FSSB Chirurgische Nadein GMBH (FSSB) and affiliated entities.

Recent FDA actions reported on Healio.com/Dermatology have included the agency expanding the approval of Opdivo plus Yervoy for all patients with unresectable or metastatic melanoma, regardless of BRAF V600 mutational status.

Recent findings published in Clinical Infectious Diseases showed that diabetes and obesity were associated with as much as a fivefold increased risk for invasive group A Streptococcus.

The FDA recently expanded the indication for the Integra Omnigraft Dermal Regeneration Matrix for the treatment of certain diabetic foot ulcers, according to a company press release.

A novel technique for large full-thickness scalp defects that can be performed on an outpatient basis with minimal wound care resulted in low morbidity, according to study results.